Evofem Biosciences Signs Non-Binding Letter of Intent to Enable Listing on a National Stock Exchange

SAN DIEGO, Aug. 22, 2023 /PRNewswire/ — Evofem Biosciences, Inc. (OTCQB: EVFM) (Evofem or the Company) today announced it has signed a confidential non-binding letter of intent (LOI) relating to a possible merger with a publicly-traded entity which, if consummated, could result in Evofem…

Click here to view original post